Certified by Founder Lodge
Synthekine
United States - Menlo Park, California
START UP
1 Disclosed Funding Rounds $100,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate tr
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 06 ,2023 | Series C | $100,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Theranautilus | $1,200,000 | (Nov 19, 2024)
SuperAnnotate | $36,000,000 | (Nov 19, 2024)
Plantible | $30,000,000 | (Nov 19, 2024)
ANELLO Photonics | Undisclosed Amount | (Nov 19, 2024)
Bluespine | $7,200,000 | (Nov 19, 2024)
